PolyBio and the Wallace Research Foundation have awarded a new grant to Dr. Michela Locci at the University of Pennsylvania to investigate impaired antibody responses in Long COVID. Building on prior findings that B cells in some patients generate weaker, short-lived antibodies, the study will explore whether Epstein-Barr virus disrupts immune function using advanced single-cell and organoid approaches. The post New grant expands Long COVID lymph node study appeared first on PolyBio Research ...| PolyBio Research Foundation
Medford MA, August 12, 2025 - A new scientific review written by PolyBio's core team challenges the long-held assumption that human aging unfolds in a sterile environment. The post Infections can be major drivers of aging processes, new PolyBio review delineates appeared first on PolyBio Research Foundation.| PolyBio Research Foundation
Dr. Proal, along with other members of the Long COVID Research Consortium, have joined SPEAR, a leading clinical and translational research team convened by Invivyd, Inc. to accelerate Long COVID clinical trials.| PolyBio Research Foundation
PolyBio Research Appoints Sarah Kalloch as Chief Operating and Innovation Officer Medford MA July 17, 2025 – PolyBio Research Foundation announces...| PolyBio Research Foundation
Medford MA, June 19 – PolyBio President and Research Director Dr. Amy Proal joined the Boston Aging Code Summit this past...| PolyBio Research Foundation
Collaborative research uncovers immune and biomarker patterns that could help subclassify ME/CFS and guide future treatments. Medford MA – May 16,...| PolyBio Research Foundation
Medford MA, April 28, 2025 — A new PolyBio-supported study published today in Nature Immunology sheds light on the biological underpinnings... The post PolyBio-supported study uncovers plasma signatures associated with long COVID respiratory symptoms appeared first on PolyBio Research Foundation.| PolyBio Research Foundation
New preprint study reveals profound and long-lasting biological disruptions that can follow a SARS-CoV-2 infection, including changes connected to altered metabolism... The post PolyBio-supported study reveals long-term immune and metabolic damage after COVID-19 infection appeared first on PolyBio Research Foundation.| PolyBio Research Foundation
Medford, Mass., April 7 2025 – Dr. Amy Proal’s participation in two recent major conferences on scientific innovation highlighted a growing... The post PolyBio’s Message to Science Innovators: Curbing Persistent Infection is Great Challenge of Our Times appeared first on PolyBio Research Foundation.| PolyBio Research Foundation
Funds will support exploration of SARS-CoV-2’s potential to drive cancer, as well as continued work delineating persistence of the virus in...| PolyBio Research Foundation
PolyBio-supported study finds reduced percentages of cytotoxic natural killer cells in people with long COVID. The immune dysfunction might facilitate SARS-CoV-2...| PolyBio Research Foundation
Project Summary: The PASC Tissue Program is the first in the world to comprehensively sample multiple tissues including gut, lymph node,...| PolyBio Research Foundation
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for...| PolyBio Research Foundation